421637006: Lyophilized powder for conventional release solution for injection (dose form)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jan 2024. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
lyofiliseret pulver til injicerbar opløsning	Is a	Powder for solution for injection	false	Inferred relationship	Some
lyofiliseret pulver til injicerbar opløsning	Has dose form administration method (attribute)	A method of administration of a dose form by introducing it into the body, usually after puncturing the skin; typically used for small volumes of liquid administered over a brief duration.	false	Inferred relationship	Some
lyofiliseret pulver til injicerbar opløsning	Has dose form transformation (attribute)	A dose form transformation that occurs when a solid dose form is mixed with a suitable liquid to create a solution. This may occur as part of the dispensing act or immediately before administration.	false	Inferred relationship	Some
lyofiliseret pulver til injicerbar opløsning	Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility.	An intended site for a dose form that is for administration by injection.	false	Inferred relationship	Some
lyofiliseret pulver til injicerbar opløsning	Has dose form release characteristic (attribute)	A release characteristic where a dose form displays a rate and time of release of the active substance(s) in the dose form based on their intrinsic properties.	false	Inferred relationship	Some
lyofiliseret pulver til injicerbar opløsning	Is a	Parenteral dose form (dose form)	false	Inferred relationship	Some
lyofiliseret pulver til injicerbar opløsning	Has basic dose form (attribute)	Lyophilized powder	false	Inferred relationship	Some
lyofiliseret pulver til injicerbar opløsning	Is a	Lyophilized powder for conventional release solution for infusion and/or injection	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Clostridium histolyticum collagenase 900 microgram powder for solution for injection vial	Has manufactured dose form	False	lyofiliseret pulver til injicerbar opløsning	Inferred relationship	Some
Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has manufactured dose form	False	lyofiliseret pulver til injicerbar opløsning	Inferred relationship	Some
Velaglucerase alfa 200unit lyophilized powder for injection solution	Has manufactured dose form	False	lyofiliseret pulver til injicerbar opløsning	Inferred relationship	Some
Product containing precisely tesamorelin (as tesamorelin acetate) 1 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has manufactured dose form	False	lyofiliseret pulver til injicerbar opløsning	Inferred relationship	Some
Product containing precisely belimumab 400 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has manufactured dose form	False	lyofiliseret pulver til injicerbar opløsning	Inferred relationship	Some
Product containing precisely belimumab 120 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has manufactured dose form	False	lyofiliseret pulver til injicerbar opløsning	Inferred relationship	Some
Canakinumab 150mg powder for injection solution	Has manufactured dose form	False	lyofiliseret pulver til injicerbar opløsning	Inferred relationship	Some
Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has manufactured dose form	False	lyofiliseret pulver til injicerbar opløsning	Inferred relationship	Some
Product containing precisely nonacog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has manufactured dose form	False	lyofiliseret pulver til injicerbar opløsning	Inferred relationship	Some
Product containing precisely nonacog alfa 1000 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has manufactured dose form	False	lyofiliseret pulver til injicerbar opløsning	Inferred relationship	Some
Product containing precisely nonacog alfa 500 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has manufactured dose form	False	lyofiliseret pulver til injicerbar opløsning	Inferred relationship	Some
Product containing precisely human immunoglobulin G 6 gram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has manufactured dose form	False	lyofiliseret pulver til injicerbar opløsning	Inferred relationship	Some
Product containing precisely mitomycin 40 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has manufactured dose form	False	lyofiliseret pulver til injicerbar opløsning	Inferred relationship	Some
Product containing precisely mitomycin 5 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has manufactured dose form	False	lyofiliseret pulver til injicerbar opløsning	Inferred relationship	Some
Product containing precisely octocog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has manufactured dose form	False	lyofiliseret pulver til injicerbar opløsning	Inferred relationship	Some
Product containing precisely octocog alfa 500 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has manufactured dose form	False	lyofiliseret pulver til injicerbar opløsning	Inferred relationship	Some
Product containing precisely teduglutide 5 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has manufactured dose form	False	lyofiliseret pulver til injicerbar opløsning	Inferred relationship	Some
Product containing precisely onabotulinumtoxinA 200 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has manufactured dose form	False	lyofiliseret pulver til injicerbar opløsning	Inferred relationship	Some
Product containing precisely onabotulinumtoxinA 100 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has manufactured dose form	False	lyofiliseret pulver til injicerbar opløsning	Inferred relationship	Some
Product containing precisely canakinumab 150 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has manufactured dose form	False	lyofiliseret pulver til injicerbar opløsning	Inferred relationship	Some
Product containing precisely lurbinectedin 4 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has manufactured dose form	False	lyofiliseret pulver til injicerbar opløsning	Inferred relationship	Some
Product containing precisely azacitidine 100 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has manufactured dose form	False	lyofiliseret pulver til injicerbar opløsning	Inferred relationship	Some
Product containing precisely remimazolam (as remimazolam besylate) 20 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has manufactured dose form	False	lyofiliseret pulver til injicerbar opløsning	Inferred relationship	Some
Product containing precisely Clostridium histolyticum collagenase 900 microgram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has manufactured dose form	False	lyofiliseret pulver til injicerbar opløsning	Inferred relationship	Some
Product containing precisely trilaciclib (as trilaciclib dihydrochloride) 300 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has manufactured dose form	False	lyofiliseret pulver til injicerbar opløsning	Inferred relationship	Some

Reference Sets

Concept inactivation indicator reference set

REPLACED BY association reference set (foundation metadata concept)

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3636025015	Lyophilized powder for conventional release solution for injection (dose form)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3636026019	Lyophilised powder for conventional release solution for injection	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3636027011	Lyophilized powder for conventional release solution for injection	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3636028018	Lyophilized powder for solution for injection	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3636029014	Lyophilised powder for solution for injection	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3866791000005114	lyofiliseret pulver til injicerbar opløsning	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)